Your browser doesn't support javascript.
loading
Long term results from a prospective database on high dose rate (HDR) interstitial brachytherapy for primary cervical carcinoma.
Fallon, Julia; Park, Sang-Jung; Yang, Lisa; Veruttipong, Darlene; Zhang, Mingle; Van, Thanh; Wang, Pin-Chieh; Fekete, Alexandra M; Cambeiro, Mauricio; Kamrava, Mitchell; Steinberg, Michael L; Demanes, D Jeffrey.
Afiliação
  • Fallon J; California Endocurietherapy at UCLA, Department of Radiation Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, United States.
  • Park SJ; California Endocurietherapy at UCLA, Department of Radiation Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, United States.
  • Yang L; California Endocurietherapy at UCLA, Department of Radiation Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, United States.
  • Veruttipong D; California Endocurietherapy at UCLA, Department of Radiation Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, United States.
  • Zhang M; California Endocurietherapy at UCLA, Department of Radiation Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, United States.
  • Van T; California Endocurietherapy at UCLA, Department of Radiation Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, United States.
  • Wang PC; California Endocurietherapy at UCLA, Department of Radiation Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, United States.
  • Fekete AM; California Endocurietherapy at UCLA, Department of Radiation Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, United States.
  • Cambeiro M; California Endocurietherapy at UCLA, Department of Radiation Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, United States.
  • Kamrava M; California Endocurietherapy at UCLA, Department of Radiation Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, United States.
  • Steinberg ML; California Endocurietherapy at UCLA, Department of Radiation Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, United States.
  • Demanes DJ; California Endocurietherapy at UCLA, Department of Radiation Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, United States. Electronic address: jdemanes@mednet.ucla.edu.
Gynecol Oncol ; 2016 Oct 29.
Article em En | MEDLINE | ID: mdl-28029448
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article